Showing results (251-260 of 618) with videos related to
Sort By:
Pageof 62
Cancer Research Communications|March 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant GliomaKristina Fanucci, Mary Jo Pilat, Derek Shyr, et al.Neuro-Oncology|December 18, 2019
Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effortAli S Haider, Martin van den Bent, Patrick Y Wen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomasHoward A Fine, Patrick Y Wen, Elizabeth A Maher, et al.Journal of Neurosurgery|October 25, 2014
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewLeland Rogers, Igor Barani, Marc Chamberlain, et al.Scientific Reports|September 10, 2021
Genomic landscape of gliosarcoma: distinguishing features and targetable alterationsMark M Zaki, Leila A Mashouf, Eleanor Woodward, et al.Neuro-Oncology|June 1, 2023
A genomic score to predict local control among patients with brain metastases managed with radiationNayan Lamba, Daniel N Cagney, Paul J Catalano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform TrialPatrick Y Wen, Donald A Berry, Meredith B Buxton, et al.Neuro-Oncology|August 22, 2022
National-level overall survival patterns for molecularly-defined diffuse glioma types in the United StatesQuinn T Ostrom, Madison L Shoaf, Gino Cioffi, et al.Epilepsy Research|April 3, 2014
Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging studyJong Woo Lee, Andrew D Norden, Keith L Ligon, et al.Pageof 62